Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Radiation Injuries × endostar protein × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 14 Nasopharyngeal Carcinoma 7 Lung Neoplasms 7 Uterine Cervical Neoplasms 3 Melanoma 3 Esophageal Squamous Cell Carcinoma 3 Nasopharyngeal Neoplasms 2 Lymphoma, T-Cell 2 Colorectal Neoplasms 2 Breast Neoplasms 2 Stomach Neoplasms 1 Sarcoma 1 Recurrence 1 Radiation Injuries 1 Quality of Life 1 Osteosarcoma 1 Neuroblastoma 1 Lymphoma, T-Cell, Peripheral 1 Head and Neck Neoplasms 1 Gastrointestinal Neoplasms 1 Esophageal Neoplasms 1 Esophageal 1 Carcinoma, Hepatocellular 1 Bone Neoplasms 1 Advanced Pancreatic Cancer 1 Advanced Gastric Cancer 1 Advanced Colorectal Cancer 1

Interventions

Radiotherapy 24 Radiotherapy, Intensity-Modulated 8 Radiosurgery 6 Amifostine 5 Low-Level Light Therapy 4 Donepezil 4 Cisplatin 4 Carboplatin 4 Surveys and Questionnaires 3 Radiation 3 Proton Therapy 3 Paclitaxel 3 Neuropsychological Tests 3 Etoposide 3 Chemotherapy, Adjuvant 3 Brachytherapy 3 Bevacizumab 3 Surgical Procedures, Operative 2 Patient Reported Outcome Measures 2 Mental Status and Dementia Tests 2 Heavy Ion Radiotherapy 2 Esophagectomy 2 Chemoradiotherapy 2 Adrenal Cortex Hormones 2 sodium propionate 1 sargramostim 1 olaparib 1 endostar protein 1 delta 24-sterol reductase 1 beta Carotene 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04274270 2020-03-19

SBRTLCES

Peking University Third Hospital

Phase NA Unknown

Lung Neoplasms, Radiation Injuries

Data powered by HemOnc (CC BY 4.0) Colophon ⚡